PubMed

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.

Worm SW, Friis-Møller N, Bruyand M, Monforte AD, Rickenbach M, Reiss P, El-Sadr W, Phillips A, Lundgren J, Sabin C; for the D:A:D study group.

AIDS. 2009 Nov 11. [Epub ahead of print]PMID: 19910787 [PubMed - as supplied by publisher]Related articles

Conventional cardiovascular risk factors in HIV infection: how conventional are they?

Sabin CA, Worm SW.

Curr Opin HIV AIDS. 2008 May;3(3):214-9.PMID: 19372969 [PubMed - in process]Related articles

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N.

Circulation. 2009 Feb 17;119(6):805-11. Epub 2009 Feb 2.PMID: 19188509 [PubMed - indexed for MEDLINE]Related articlesFree article

Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.

Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte A, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N.

Diabetes Care. 2009 Mar;32(3):474-80. Epub 2008 Dec 3.PMID: 19056612 [PubMed - indexed for MEDLINE]Related articlesFree article

Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.

Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Dávila-Román VG, D'Agostino RB Sr, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW; Working Group 5.

Circulation. 2008 Jul 8;118(2):e48-53. Epub 2008 Jun 19. No abstract available. PMID: 18566316 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1417-26. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292. PMID: 18387667 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Møller N, Phillips A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Diabetes Care. 2008 Jun;31(6):1224-9. Epub 2008 Feb 11.PMID: 18268071 [PubMed - indexed for MEDLINE]Related articlesFree article

Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools?

Friis-Møller N, Worm SW.

Clin Infect Dis. 2007 Oct 15;45(8):1082-4. Epub 2007 Sep 12. No abstract available. PMID: 17879929 [PubMed - indexed for MEDLINE]Related articles

Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited.

Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T.

BMC Infect Dis. 2004 Jun 30;4:21.PMID: 15228629 [PubMed - indexed for MEDLINE]Related articlesFree article